A study led by researchers from the Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, revealed a new liver- and ...

Researchers developed TLC-2716, a liver- and gut-targeted drug that selectively reduced LXR activity, lowering triglycerides, ...

It is already known that heart problems and diseases are caused by excess bad fat.High levels of triglycerides, a type of fat ...

New peer-reviewed clinical research examines the role of omega-3 delivery architecture in triglyceride outcomes and omega-3 incorporation.

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...

Not all proteins function the same way in the body, especially when it comes to heart health. In a review of controlled ...

With so many misleading labels in the supermarket, it’s not always easy to tell which foods are good for your cardiovascular ...

OrsoBio has announced the publication in Nature Medicine of Phase I clinical trial data for TLC-2716, an oral liver-targeted ...

CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...

A randomized crossover feeding trial in adults aged 65 years or older found that plant-forward diets incorporating either ...

"One of the easiest things to remember if you want to lose weight and live longer through diet is simply stop snacking," Dan ...

Wishing all of you a very happy and healthy 2026! However, if wishes were enough to drive action, we would already all be ...